Benzo(α)pyrene-induced up-regulation of CYP1A2 gene expression: Role of adrenoceptor-linked signaling pathways

Life Sciences

Volumn 79, Issue 4, 2006, Pages 331-341

  Konstandi, Maria ^a   Kostakis, Dimitris ^a   Harkitis, Panagiotis ^a   Johnson, Elizabeth O ^a   Marselos, Marios ^a   Adamidis, Konstadinos ^a   Lang, Matti A ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adrenoceptors; Benzo( )pyrene; Catecholamines; CYP1A2; Rat

Indexed keywords

7 METHOXYRESORUFINO DEMETHYLASE; ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BENZO[A]PYRENE; CATECHOLAMINE; CYTOCHROME P450 1A2; DEXMEDETOMIDINE; ENZYME; GUANETHIDINE; LEVODOPA; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RESERPINE; UNCLASSIFIED DRUG;

ADRENALIN RELEASE; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BENZO(A)PYRENE; CATECHOLAMINES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DEXMEDETOMIDINE; EPINEPHRINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANETHIDINE; LEVODOPA; MALE; OXIDOREDUCTASES; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RESERPINE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYMPATHOLYTICS; UP-REGULATION;

EID: 33744526253     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.01.012     Document Type: Article

References (38)

1. Barbeau A., and Roy M. Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease. Neurology 26 5 (1976) 399-404
2. Burke M.D., and Majer R.T. Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metabolism and Disposition 3 (1975) 245-253
3. Cherng S.H., Lin P., Yang J.L., Hsu S.L., and Lee H. Benzo[g,h,I]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1gene expression by Aryl hydrocarbon receptor pathway. Toxicology and Applied Pharmacology 170 (2001) 63-68
4. Cooper J.R., Bloom F.E., and Roth R.H. Norepinephrine and epinephrine-adrenergic receptors. In: House J. (Ed). The Biochemical Basis of Neuropharmacology. Seventh Edition (1996), Oxford University Press, New York 258-264
5. Daniel W.A., Syrek M., and Haduch A. The contribution of cytochrome P450 isoenzymes to the metabolism of phenothiazine neuroleptics. European Neuropsychopharmacology 12 5 (2002) 371-377
6. De Paula Brotto M.A. Temporal effects of stress by immobilization and sensitivity of the isolated rat pacemaker to isoproterenol: roles of corticosterone, neuronal uptake, and β-adrenergic homogeneity. Journal of Pharmacology and Experimental Therapeutics 306 3 (2003) 1152-1158
7. Fuhr U., and Rost K.L. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and saliva. Pharmacogenetics 4 (1994) 109-116
8. Glavin G.B. Stress and noradrenaline: a review. Neuroscience Biobehavioral Reviews 9 (1985) 233-243
9. Gonzalez F.J. The molecular biology of the cytochrome P450s. Pharmacological Reviews 40 (1989) 243-288
10. Guengerich F.P., Parikh A., Turesky R.J., and Josephy P.D. Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype. Mutation Research 428 1-2 (1999) 115-124
11. IARC (International Agency for Research on Cancer). Polynuclear aromatic compounds, Part 1, Chemical, environmental and experimental data. IARC, Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans vol. 32 (1983) Lyon-France
12. Ioannides C., and Parke D.V. The cytochrome P450I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metabolism Reviews 22 1 (1990) 1-85
13. Johnson E.O., Kamilaris T.C., Chrousos G., and Gold P.W. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neuroscience and Biobehavioral Reviews 16 (1992) 115-130
14. Kadlubar F.F., Talaska G., Bulter M.A., Teitel C.H., Hassengill J.P., and Lang N.P. Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites. In: Mendelsohn M.L., and Albertini R.J. (Eds). Mutation and the Environment. Part B: Metabolism, Testing Methods and Chromosomes (1990), John Wiley and Sons, New York 107-114
15. Konstandi M., Kostakis D., Johnson E.O., Lang M.A., and Marselos M. Evidence of α2-adrenoceptor involvement in B[α]P induction processes of drug-metabolizing enzymes: the effect of stress. European Journal of Drug Metabolism and Pharmacokinetics 23 4 (1998) 491-495
16. Konstandi M., Johnson E.O., Lang M.A., Camus-Radon A.M., and Marselos M. Stress modulates the enzymatic inducibility by benzo[α]pyrene in the rat liver. Pharmacological Research 42 3 (2000) 205-211
17. Konstandi M., Johnson E.O., Marselos M., Kostakis D., Fotopoulos A., and Lang M.A. Stress-mediated modulation of B(α)P-induced hepatic CYP1A1: role of catecholamines. Chemico-Biological Interactions 147 (2004) 65-77
18. Konstandi M., Kostakis D., Harkitis P., Marselos M., Johnson E.O., Adamidis K., and Lang M.A. Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression. Biochemical Pharmacology 69 (2005) 277-287
19. Koulu M., Pesonen U., and Virtanen R. Chronic dexmedetomidine, a selective alpha 2-agonist, decreases serotonin but not noradrenaline turnover in rat brainstem nuclei. Euopean Journal of Pharmacology 176 2 (1990) 151-157
20. 2-adrenoceptors. Biochemical Pharmacology 67 (2004) 87-96
21. Landi M.T., Sinha R., Lang N.P., and Kadlubar F.F. Human cytochrome P4501A2. IARC Scientific Publications 148 (1999) 173-195
22. Lang M.A., Gielen J.E., and Nebert D.W. Genetic evidence for many unique liver microsomal P-450 mediated monoxygenase activities in heterogenetic stock mice. The Journal of Biological Chemistry 256 23 (1981) 12068-12075
23. Llibre J.M., Romeu J., Lopez E., and Sirera G. Severe interaction between ritonavir and acenocoumarol. The Annals of Pharmacotherapy 36 4 (2002) 621-623
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 193 (1951) 265-275
25. Mattheij J.A., Brouwer G.M., Hanstede J.G., and Swarts J.J. No evidence for a peripheral effect of L-DOPA on plasma prolactin in the rat. Life Sciences 31 9 (1982) 915-921
26. Mefford I.N. Application of high performance chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. Journal of Neuroscience Methods 3 (1981) 207-224
27. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochemical Pharmacology 59 1 (2000) 65-85
28. Pelkonen O., and Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacological Reviews 34 (1982) 189-222
29. Pelkonen O., and Raunio H. Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. Environmental Health Perspectives 105 (1997) 767-774
30. Rayan D.E., Thomas P.E., and Levin W. Hepatic microsomal cytochrome P-450 from rats treated with isosafrole; purification and characterization of four forms. The Journal of Biological Chemistry 255 (1980) 7941-7955
31. Scheinin M., and MacDonald E. An introduction to the pharmacology of alpha 2-adrenoceptors in the central nervous system. Acta Veterinaria Scandinavica Supplements, Review 85 (1989) 11-19
32. Shimada T., Iwasaki M., Martin M.V., and Guengerich F.P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in salmonella typhimurium TA 1535/pSK1002. Cancer Research 49 (1989) 3218-3228
33. Sogawa K., Gotoh O., Kawajiri K., and Fujii-Kuriyama Y. Distinct organization of methylcholanthrene- and phenobarbital-inducible cytochrome P-450 genes in the rat. Proceeding of National Academy of Sciences of the United States of America 81 16 (1984) 5066-5070
34. Soucek P., and Gut I. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica, Review 22 1 (1992) 83-103
35. Tuomisto J., and Mannisto P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacological Reviews 37 (1985) 249-332
36. Virtanen R. Pharmaceutical profiles of metedomidine and its antagonist, atipamezole. Acta Veterinaria Scandinavica 85 (1989) 29-37
37. Yamazaki H., Komatsu T., Takemoto K., Shimada N., Nakajima M., and Yokoi T. Rat cytochrome P4501A and 3A enzymes involved in bioactivation of tegafur to 5-fluorouracil and autoinduced by tegafur in liver microsomes. Drug Metabolism and Disposition 29 6 (2001) 794-779
38. Yamazoe Y., Shimada M., Murayama N., and Kato R. Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. The Journal of Biological Chemistry 262 (1987) 7423-7428